Category - Any -CorporateScience Apply Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma Mon, 12/09/2024 - 00:00 Read more about Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma ANKET: Our NK cell engager platform Thu, 06/10/2021 - 07:00 Click here to learn more about ANKETTM Read more about ANKET: Our NK cell engager platform Interview of Eric Vivier “The new generation of NK cell therapies” Fri, 02/05/2021 - 08:00 Interview Eric Vivier "The new generation of NK cell therapies" Read more about Interview of Eric Vivier “The new generation of NK cell therapies” Nasdaq #BehindTheBell (October 17, 2019) Wed, 10/30/2019 - 09:45 Read more about Nasdaq #BehindTheBell (October 17, 2019) Nasdaq Closing Bell Ceremony (October 17, 2019) Fri, 10/18/2019 - 09:30 Read more about Nasdaq Closing Bell Ceremony (October 17, 2019) Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma Mon, 12/09/2024 - 00:00 Read more about Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma
ANKET: Our NK cell engager platform Thu, 06/10/2021 - 07:00 Click here to learn more about ANKETTM Read more about ANKET: Our NK cell engager platform
Interview of Eric Vivier “The new generation of NK cell therapies” Fri, 02/05/2021 - 08:00 Interview Eric Vivier "The new generation of NK cell therapies" Read more about Interview of Eric Vivier “The new generation of NK cell therapies”
Nasdaq #BehindTheBell (October 17, 2019) Wed, 10/30/2019 - 09:45 Read more about Nasdaq #BehindTheBell (October 17, 2019)
Nasdaq Closing Bell Ceremony (October 17, 2019) Fri, 10/18/2019 - 09:30 Read more about Nasdaq Closing Bell Ceremony (October 17, 2019)
